In a clinical study conducted by Ritter Pharmaceuticals former board member Chris Landon, M.D., Lactagen showed a statistically significant reduction in lactose intolerance symptoms among sixty-subjects in a double-blind clinical trial at the Ventura County Medical Center in Los Angeles, California.
Lactagen showed a statistically significant reduction in lactose intolerance symptoms among sixty-subjects in a double-blind clinical trial at the Ventura County Medical Center in Los Angeles, California. This was in a clinical study. This clinical study was conducted by Ritter Pharmaceuticals former board member Chris Landon. Ritter Pharmaceuticals former board member Chris Landon was M.D..